Miyamoto-Mikami Eri, Murakami Haruka, Tsuchie Hiroyasu, Takahashi Hideyuki, Ohiwa Nao, Miyachi Motohiko, Kawahara Takashi, Fuku Noriyuki
Japan Society for the Promotion of Science, Japan; Department of Sports and Life Science, National Institute of Fitness and Sports in Kanoya, Japan.
Department of Health Promotion and Exercise, National Institute of Health and Nutrition, NIBIOHN, Japan.
J Sci Med Sport. 2017 Jan;20(1):98-103. doi: 10.1016/j.jsams.2016.06.005. Epub 2016 Jun 23.
This study aimed to examine the association between a total genotype score (TGS) based on previously published genetic polymorphism candidates and differences in sprint/power performance.
Case-control association study.
We analysed 21 polymorphisms, which have previously been associated with sprint/power performance and related phenotypes, in 211 Japanese sprint/power track and field athletes (77 regional, 72 national, and 62 international athletes) and 649 Japanese controls using the TaqMan SNP genotyping assay. We calculated the TGS (maximum value of 100 for the theoretically optimal polygenic score) for the 21 polymorphisms.
All groups exhibited similar TGSs (control: 55.9±7.2, regional: 55.1±7.1, national: 56.1±7.4, and international: 56.0±7.8, p=0.827 by one-way analysis of variance). Nine of the 21 polymorphisms had the same direction of effect (odds ratio >1.0) as in previous studies, while 12 had the opposite direction of effect (odds ratio <1.0). Three polymorphisms (rs699 in AGT, rs41274853 in CNTFR, and rs7832552 in TRHR), which had the same direction of effect as in previous studies, were associated with international sprint/power athlete status (p<0.05). However, after multiple testing corrections, the statistical significance of these polymorphisms was not retained.
These results suggest that TGSs based on the 21 previously published sprint/power performance-associated polymorphisms did not influence the sprint/power athlete status of Japanese track and field athletes. However, our results maintain the possibility that three of these polymorphisms might be associated with sprint/power performance.
本研究旨在探讨基于先前公布的基因多态性候选指标的总基因型评分(TGS)与短跑/力量表现差异之间的关联。
病例对照关联研究。
我们使用TaqMan SNP基因分型检测法,对211名日本短跑/力量项目田径运动员(77名地区级、72名国家级和62名国际级运动员)和649名日本对照者分析了21种先前已与短跑/力量表现及相关表型相关的多态性。我们计算了这21种多态性的TGS(理论上最优多基因评分的最大值为100)。
所有组的TGS相似(对照组:55.9±7.2,地区级:55.1±7.1,国家级:56.1±7.4,国际级:56.0±7.8,单因素方差分析p = 0.827)。21种多态性中有9种的效应方向(优势比>1.0)与先前研究相同,而12种的效应方向相反(优势比<1.0)。三种与先前研究效应方向相同的多态性(AGT中的rs699、CNTFR中的rs41274853和TRHR中的rs7832552)与国际短跑/力量运动员身份相关(p<0.05)。然而经多重检验校正后,这些多态性的统计学显著性未保留。
这些结果表明,基于先前公布的21种与短跑/力量表现相关的多态性的TGS并未影响日本田径运动员的短跑/力量运动员身份。然而,我们的结果仍表明这些多态性中的三种可能与短跑/力量表现相关。